Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Adler Real Estate AG

Start price
Target price
Perf. (%)
€7.24
11.01.22
€8.00
11.01.23
-11.46%
24.01.22

Low dividend yield expected
negative Cash Flow expected
Few uniques
Dependend from some customers or products
buy
Max Automation AG

Start price
Target price
Perf. (%)
€4.59
11.01.22
-
11.01.23
5.23%
12.01.23

buy
Osmotica Pharmaceuticals PLC

Start price
Target price
Perf. (%)
€1.01
11.01.22
€1.50
11.01.23
12.87%
12.01.23

Could be worthwhile Investment >10% per year
buy
STO SE & Co. KGaA

Start price
Target price
Perf. (%)
€241.50
11.01.22
-
11.01.23
-36.07%
12.01.23

buy
Salzgitter AG

Start price
Target price
Perf. (%)
€35.00
11.01.22
-
11.01.23
-9.49%
12.01.23

buy
2G Energy AG

Start price
Target price
Perf. (%)
€98.40
10.01.22
€115.00
10.01.23
-1.42%
21.02.22

Top 10 in its market
Revenue growth >5% per year expected
Sustainability is very important
Significant cyclical dependencies
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€25.00
10.01.22
-
10.01.23
-22.72%
23.01.22

Risky Investment
buy
Ata Inc. ADR

Start price
Target price
Perf. (%)
€2.10
09.01.22
€2.50
09.01.23
-39.17%
10.01.23

Some uniques
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.02
09.01.22
-
09.01.23
-18.54%
23.01.22

Could be very worthwhile Investment >20% year
buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.81
09.01.22
-
09.01.23
-12.41%
23.01.22

Could be very worthwhile Investment >20% year
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.66
09.01.22
€0.20
09.01.23
-1.09%
21.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
SNP Schneider-Neureither & Partner AG

Start price
Target price
Perf. (%)
€36.36
09.01.22
€27.00
09.01.23
-19.91%
16.03.22

high free float
Higher risks for its business
Very high cyclical dependencies
Little known brand
buy
Frequentis AG

Start price
Target price
Perf. (%)
€33.70
09.01.22
€38.00
09.01.23
-22.85%
24.01.22

Future proof or reliable business model
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Overstock.com

Start price
Target price
Perf. (%)
€47.35
09.01.22
-
09.01.23
-3.13%
10.02.22

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€3.71
09.01.22
-
09.01.23
-11.02%
22.01.22

Could be worthwhile Investment >10% per year
buy
Takkt AG

Start price
Target price
Perf. (%)
€15.40
09.01.22
€18.00
09.01.23
-0.52%
22.01.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
Gamestop Corp.

Start price
Target price
Perf. (%)
€31.23
09.01.22
-
09.01.23
-32.39%
21.01.22

Risky Investment
overvalued
Outdated or very high risk business model
High risks in the balance sheet
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.26
09.01.22
-
09.01.23
7.05%
10.01.23

Risky Investment
buy
Uranium Energy Corp

Start price
Target price
Perf. (%)
€3.47
08.01.22
-
08.01.26
-1.31%
27.06.22

Could be worthwhile Investment >10% per year
buy
Psi AG

Start price
Target price
Perf. (%)
€42.40
08.01.22
€52.00
08.04.22
-4.13%
08.04.22

Some uniques
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
buy
BICO Group AB

Start price
Target price
Perf. (%)
€22.96
08.01.22
€44.00
08.01.23
-7.93%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€5.42
08.01.22
€10.00
08.01.23
-11.22%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
CropEnergies AG

Start price
Target price
Perf. (%)
€12.70
08.01.22
-
08.01.23
12.91%
09.01.23

Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected